Completed PHASE4 INTERVENTIONAL NCT00235092

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

A Prospective, Randomized, Multi-Center Comparison of the Cypher Sirolimus-Eluting and the Taxus Paclitaxel-Eluting Stent Systems.

Sponsor: Cordis US Corp.

Conditions Coronary Artery Disease

Interventions Cypher Sirolimus-Eluting Stent Taxus Paclitaxel-Eluting Stent

Updated 6 times since 2017 Last updated: Apr 25, 2007 Started: Aug 31, 2003 Completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Coronary Artery Disease and is currently completed. Cordis US Corp. leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Dec 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Dec 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cordis US Corp.

Data source: Cordis US Corp.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Massy, France